otcbargains undervalued stock board

[Hegotgame]

ASDS News....Ascendant Solutions, Inc. Reports Second Quarter 2013 Earnings, Earnings
per Share and EBITDA


DALLAS, Aug. 19, 2013 /PRNewswire via COMTEX/ -- Ascendant Solutions, Inc.
(Pink Sheets: ASDS) ("Ascendant" or the "Company") today announced its results
for the second quarter of fiscal 2013. The Company reported consolidated net
income of $271,000 for the fiscal quarter ended June 30, 2013, compared to net
loss of $375,000 in 2012, resulting in net income per share ("EPS") of $0.01
compared to net loss per share of $0.02. Consolidated net income for the six
months ended June 30, 2013 was $844,000, compared to net loss of $569,000 for
the six months ended 2012, resulting in net income per share of $0.03 compared
to net loss per share of $0.02. Average common shares outstanding for 2013 and
2012 were 24,447,931.

For the fiscal quarter ended June 30, 2013, the Company reported Consolidated
Earnings (Loss) before Interest, Taxes, Depreciation and Amortization ("EBITDA")
of $388,000 compared to consolidated EBITDA of ($223,000) in 2012. EBITDA for
the six months ended June 30, 2013, was $1,082,000 compared to ($268,000) for
the same period of 2012.

Healthcare

The Company's subsidiary, Dougherty's Holding, Inc. ("DHI") which owns and
operates multiple Dougherty's Pharmacies, reported EBITDA of $460,000 for the
fiscal quarter ended June 30, 2013, compared to $213,000 in 2012. EBITDA for the
six months ended June 30, 2013, was $834,000 compared to $395,000 for the same
period of 2012.

Real Estate and Other

The Company's real estate and other subsidiaries reported EBITDA of ($72,000)
for the fiscal quarter ended June 30, 2013, compared to ($436,000) in 2012.
EBITDA for the six months ended June 30, 2013, was $248,000 compared to
($663,000) for the same period of 2012.

Jim Leslie, Chairman, commented, "We continue to achieve outstanding quarterly
performances in our healthcare segment and look forward to continued positive
results during 2013. Aided by an improving economy, Ascendant is exploring
potential strategic acquisitions in our healthcare segment to enhance
shareholder value over the long term. Our shareholders can find up-to-date
financial information on Ascendant at OTCMarkets.com."

Mark Heil, Chief Financial Officer, explained, "Ascendant's continued
improvements in net income during Q2 2013 was again attributable to successful
cuts in overhead, stabilizing operational earnings at Dougherty's Pharmacy and
successful exits in two of our portfolio companies in our real estate and other
business segment. The Company experienced strong cash flows allowing for the
reduction of long term debt on our balance sheet."

EBITDA is calculated as net income (loss) before deducting interest, taxes,
depreciation and amortization. Although EBITDA is not a measure of actual cash
flow because it does not consider changes in assets and liabilities that may
impact cash balances, the Company's management reviews these non-GAAP financial
measures internally to evaluate the Company's performance and manage the
operations. Additionally, the Company believes it is a useful metric to evaluate
operating performance and has therefore included such measures in the reporting
of operating results.



Select Balance Sheet Items and Book Value per Share

(000's omitted, except per share amounts, unaudited)



June 30, December 31,

2013 2012



Total Current Assets $ 3,946 $ 3,487

Property and Equipment, net 982 1,023

Equity Method Investments 5,107 5,107

Deferred Tax Asset 3,000 3,000

Long term receivable 109 -

Total Assets $ 13,144 $ 12,617



Total Current Liabilities $ 2,630 $ 2,501

Notes Payable, Long-Term 2,459 2,905

Total Liabilities 5,089 5,406

Stockholders' Equity 8,055 7,211

Total Liabilities and Equity $ 13,144 $ 12,617



Common Shares Outstanding 24,447,931 24,447,931

Book Value per Share $ 0.33 $ 0.29



About Ascendant Solutions, Inc.

Ascendant Solutions, Inc. is a value oriented investment firm focused on making
equity investments in lower middle-market U.S. companies with annual revenues up
to $150 million. Ascendant looks to invest in or acquire pharmacies and
businesses in the healthcare, manufacturing, finance and real estate industries.
These businesses may require access to capital or capital restructuring due to
start-ups, growth, desire to exit or distress situations and many are in need of
strategic support to improve operational performance. Ascendant currently has
approximately $44 million in net operating loss carryforwards which can be used
to shelter future income, thus enhancing free cash flow or debt service
capabilities. Ascendant specializes in solving complex transactions where
creative and timely solutions can add value to an enterprise.

SOURCE Ascendant Solutions, Inc.


http://rt.prnewswire.com/rt.gif?NewsItemId=CG66009&Transmission_Id=201308191219PR_NEWS_USPR_____CG66009&DateId=20130819



www.prnewswire.com


Copyright (C) 2013 PR Newswire. All rights reserved

-0-